Principal Financial Group’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$18M Sell
2025
Q2
$20.8M Buy
2025
Q1
$10.4M Buy
2024
Q3
Sell
2024
Q2
$223K Sell
2024
Q1
$348K Buy
2023
Q4
$278K Buy
2023
Q3
$593K Buy
2023
Q2
$532K Buy
2023
Q1
$408K Buy
2022
Q4
$512K Buy
2022
Q3
$241K Buy
2021
Q2
Sell
2021
Q1
$224K Buy